AHK-Cu: The Copper Tripeptide Studied for Hair, and How It Stacks Up Against GHK-Cu
Walk through the ingredient list of almost any "copper peptide" hair serum and you'll eventually run into two names: GHK-Cu and AHK-Cu. The first is well known and shows up everywhere in skin and hair formulations. The second is quieter, marketed almost exclusively for hair, and rests on a much thinner stack of published evidence. This entry is a research-log look at AHK-Cu — what it actually is, what the data shows, and where the marketing runs ahead of the science.
What AHK-Cu is
AHK-Cu is a synthetic tripeptide — L-alanyl-L-histidyl-L-lysine (alanine–histidine–lysine) — complexed with a copper (II) ion. In cosmetic ingredient nomenclature it's often labeled Copper Tripeptide-3. Structurally it sits in the same family as the more famous GHK-Cu (glycyl-L-histidyl-L-lysine + copper), differing by a single amino acid at the first position: alanine instead of glycine. Both are small copper-binding peptides used topically in cosmetics.
The key contrast is origin and evidence base. GHK-Cu is a naturally occurring human peptide with a broad, decades-long published literature spanning wound healing, skin remodeling, and gene expression. AHK-Cu, by comparison, was studied and marketed with a narrower focus: the hair follicle. It does not have GHK-Cu's wide research footprint — most of what's cited for AHK-Cu traces back to a small number of studies, and much of the rest is cosmetic-industry or vendor material.
The core study people actually cite
When a serum brand references "clinical research" behind AHK-Cu, the primary source is almost always one paper: Pyo et al., Archives of Pharmaceutical Research, 2007 ("The effect of tripeptide-copper complex on human hair growth in vitro," PMID 17703734), out of Seoul National University.
What that study actually did:
That's a genuinely interesting result — activity at picomolar concentrations suggests real biological potency, and the dual "promote proliferation + reduce cell death" story is a coherent one for a follicle. But it is one in-vitro/ex-vivo study. It is not a randomized, placebo-controlled trial showing hair regrowth on human heads.
Reading the mechanism claims carefully
Secondary sources — vendor pages, serum brands, peptide blogs — layer on additional mechanisms: that AHK-Cu raises VEGF to improve blood supply to the follicle, suppresses TGF-β1 to delay the catagen (shedding) phase, and keeps follicles in the growth phase longer. These are plausible and consistent with copper-peptide biology, but they are frequently stated with more confidence than the primary literature supports, and they are often blended with GHK-Cu's much larger evidence base. Treat the follicle-elongation, dermal-papilla-proliferation, and anti-apoptotic findings as the best-documented; treat the VEGF/TGF-β specifics as more tentative for AHK-Cu specifically.
AHK-Cu vs GHK-Cu
| AHK-Cu | GHK-Cu | |
|---|---|---|
| Sequence | Ala-His-Lys + Cu²⁺ | Gly-His-Lys + Cu²⁺ |
| Origin | Synthetic | Naturally occurring in humans |
| Research focus | Narrow — mostly hair follicle / dermal papilla | Broad — skin remodeling, wound repair, gene expression |
| Evidence depth | Thin; a few studies | Substantial, though much of it also cosmetic/in-vitro |
| Typical marketing | Hair growth serums | Skin and hair ("anti-aging") |
The honest summary: GHK-Cu is the broadly studied "tissue remodeler," and AHK-Cu is the narrower, hair-targeted cousin with a much smaller published record. Many serums combine both, and the theory that GHK-Cu improves the scalp environment while AHK-Cu signals the follicles directly is a marketing narrative built on top of limited head-to-head human data — not a proven synergy.
What this does and doesn't tell you
What the evidence supports: AHK-Cu is a copper tripeptide with measurable follicle-related activity in laboratory models, used topically in cosmetic serums, and it is chemically closely related to GHK-Cu.
What it does not establish: robust, independent, placebo-controlled proof that topical AHK-Cu regrows hair in people to a clinically meaningful degree. Reported effects in cosmetic contexts are generally described as modest, the strongest data is preclinical, and much of the supporting material is produced by companies selling the ingredient. That's a reason for skepticism, not a verdict.
One practical note if you're cataloging a topical copper peptide: copper complexes and peptides can be sensitive to storage conditions, and reconstituted or solution formulations don't last indefinitely. A tool like the shelf-life calculator can help you log and track that rather than guessing.
Copper peptides are one of the more genuinely interesting corners of the cosmetic-peptide world — but "interesting mechanism in a dish" and "proven on your scalp" are different claims, and the gap between them is exactly where the marketing tends to live.
PepStash is a research log and reference tool. This article is educational and is not medical advice — it does not diagnose, treat, or recommend any protocol. Regulatory status and trial data change; always verify against primary sources and consult a licensed physician before making any decisions about your health.